Showing results (951-960 of 2,345) with videos related to
Sort By:
Pageof 235
The AAPS Journal|November 26, 2014
Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticlesJulia E Vela-Ramirez, Jonathan T Goodman, Paola M Boggiatto, et al.The AAPS Journal|November 26, 2014
Summary report of PQRI Workshop on Nanomaterial in Drug Products: current experience and management of potential risksJeremy A Bartlett, Marcus Brewster, Paul Brown, et al.The AAPS Journal|January 18, 2020
Dose Correction for a Michaelis-Menten Approximation of a Target-Mediated Drug Disposition Model with a Multiple Intravenous Dosing RegimensXiaoyu Yan, Juan Jose Perez Ruixo, Wojciech KrzyzanskiThe AAPS Journal|November 17, 2020
Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder InhalersMaria F Acosta, Michael D Abrahamson, David Encinas-Basurto, et al.The AAPS Journal|September 11, 2020
Investigating the Theoretical Basis for In Vitro-In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental PathwaysLeslie Z Benet, Jasleen K SodhiThe AAPS Journal|February 12, 2020
Mechanistic Pharmacokinetic/Pharmacodynamic Model of Sunitinib and Dopamine in MCF-7/Adr Xenografts: Linking Cellular Heterogeneity to Tumour BurdenSiyuan Wang, Xiao Zhu, Mengyi Han, et al.The AAPS Journal|February 6, 2020
Correction to: Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody AssaysBoris Gorovits, Michele Fiscella, Mike Havert, et al.The AAPS Journal|February 8, 2020
Quantification of T Cell Binding Polyclonal Rabbit Anti-thymocyte Globulin in Human Plasma with Liquid Chromatography Tandem-Mass SpectrometryMohsin El Amrani, Rick Admiraal, Lobke Willaert, et al.The AAPS Journal|February 9, 2020
Reference Datasets for Studies in a Replicate Design Intended for Average Bioequivalence with Expanding LimitsHelmut Schütz, Detlew Labes, Michael Tomashevskiy, et al.The AAPS Journal|January 8, 2020
Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody AssaysBoris Gorovits, Michele Fiscella, Mike Havert, et al.Pageof 235